Kent

Executive Vice
President

Kent Thoelke is Executive Vice President, Scientific & Medical Affairs. Mr. Thoelke oversees scientific and strategic product development to empower project teams and promote the success of clients’ studies. Mr. Thoelke directs the following PRA divisions: Medical Affairs, Scientific Affairs, Global Feasibility, Medical Informatics, Patient Access and Recruitment Services, Investigator Networks, Orphan and Rare Diseases and the Infectious Disease Research Center. As a member of PRA’s executive team, he also helps manage PRA’s joint venture in China.

During his tenure at PRA, Mr. Thoelke has served as Vice President of Global Product Development Services and Senior Vice President of Scientific and Medical Affairs. Previously, he worked at Pharmaceutical Product Development, Inc. (PPD), where he held senior-level positions in hematology/oncology, global strategic drug development and corporate development. Mr. Thoelke is also a named inventor on numerous patents in high-dose radiotherapy for the treatment of hematologic malignancies.

Mr. Thoelke has over 21 years of experience in the global drug development, diagnostic and device industry, offering specialized expertise in hematology/ oncology studies. Having visited over 40 countries, he is familiar with the global drug development environment, and he has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and drug development timelines. A leader in the field of medical informatics, Mr. Thoelke focuses on leveraging data to maximize patient enrollment by selecting high-performing sites to minimize overall drug development timelines.